Background: Congenital disorders of glycosylation (CDG) and NGLY1-CDDG (NGLY1-congenital disorder of deglycosylation) usually represent multisystem (especially neurovisceral) diseases with liver involvement reported in some of them. This evidence concerns the gene NGLY1 and Alacrimia-choreoathetosis-liver dysfunction syndrome.